COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action
- PMID: 32157783
- PMCID: PMC7228204
- DOI: 10.1111/dth.13298
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action
Conflict of interest statement
The authors declare no potential conflict of interest.
Comment in
-
Antipsoriatic treatments during COVID-19 outbreak.Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10. Dermatol Ther. 2020. PMID: 32223073 Free PMC article. No abstract available.
-
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16. Dermatol Ther. 2020. PMID: 32239587 Free PMC article. No abstract available.
-
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6. J Dermatolog Treat. 2020. PMID: 32248724 No abstract available.
-
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2. Dermatol Ther. 2020. PMID: 32291828 Free PMC article. No abstract available.
-
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.J Dermatolog Treat. 2020 Jun;31(4):328-329. doi: 10.1080/09546634.2020.1757605. Epub 2020 Apr 27. J Dermatolog Treat. 2020. PMID: 32301363 No abstract available.
-
Biologics for psoriasis in COVID-19 era: What do we know?Dermatol Ther. 2020 Jul;33(4):e13467. doi: 10.1111/dth.13467. Epub 2020 Jun 15. Dermatol Ther. 2020. PMID: 32338424 Free PMC article. No abstract available.
-
Comment on "Antipsoriatic treatments during COVID-19 outbreak".Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12. Dermatol Ther. 2020. PMID: 32358882 Free PMC article. No abstract available.
-
A challenging case of psoriasis flare-up after COVID-19 infection.J Dermatolog Treat. 2020 Aug;31(5):448-449. doi: 10.1080/09546634.2020.1764904. Epub 2020 May 15. J Dermatolog Treat. 2020. PMID: 32363967 No abstract available.
-
Immunosuppressive treatment for systemic sclerosis-Therapeutic challenges during the COVID-19 pandemic.Dermatol Ther. 2020 Jul;33(4):e13619. doi: 10.1111/dth.13619. Epub 2020 Jun 30. Dermatol Ther. 2020. PMID: 32428315 Free PMC article. No abstract available.
References
-
- Kling MC, Larian AA, Scordi‐Bello I, Emer J, Lebwohl MG. Fatal influenza a (H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab. Arch Dermatol. 2010;146:651‐654. - PubMed
-
- Maza A, Montaudié H, Sbidian E, et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non plaque psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 2):19‐27. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
